Abstract
Background
Lesions of the brain denominated as unidentified bright objects (UBOs), which are not included in the diagnostic criteria for neurofibromatosis type 1 (NF1) established by the National Institutes of Health (NIH), have been detected by MRI.
Objective
The purpose of this study was to investigate the possibility of including the presence of UBOs as a diagnostic criterion for NF1 in children.
Materials and methods
The study included 88 children between the ages of 2 and 18 years. The case group consisted of 40 children diagnosed with sporadic or familial NF1 according to the criteria established by the NIH. A control group consisted of 48 individuals referred for routine MRI of the brain for other complaints not related to NF1.
Results
UBOs were identified in 70% of the NF1 patients and in none of the control group. The sensitivity of the presence of UBOs for the diagnosis of NF1 was 70% (CI 53–83%), with a false-negative rate of 30% (CI 27–47%), a specificity of 100% (CI 86–100%) and a false-positive rate of 0% (CI 0–14%).
Conclusion
Faced with the difficulties in diagnosing NF1 in children and the high frequency and specificity of the presence UBOs identified by MRI in our series, we recommend the inclusion of the presence UBOs as a diagnostic criterion for NF1 in children.
Similar content being viewed by others
References
Rodriguez D, Young Poussaint T (2004) Neuroimaging findings in neurofibromatosis type 1 and 2. Neuroimaging Clin N Am 14:149–170
Viskochil D (2002) Genetics of neurofibromatosis 1 and the NF1 gene. J Child Neurol 17:562–570
Steen RG, Taylor JS, Langston JW et al (2001) Prospective evaluation of the brain in asymptomatic children with neurofibromatosis type 1: relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities. AJNR 22:810–817
Mentzel HJ, Seidel J, Fitzek C et al (2005) Pediatric brain MRI in neurofibromatosis type 1. Eur Radiol 15:814–822
Pinson S, Wolkenstein P (2005) Neurofibromatosis type 1 or Von Recklinghausen’s disease. Rev Med Interne 26:196–215
DeBella K, Szudek J, Friedman JM (2000) Use of the National Institutes of Health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics 105:608–614
National Institutes of Health Consensus Development Conference (1988) Neurofibromatosis. Conference statement. Arch Neurol 45:575–578
Brown EW, Riccardi VM, Mawad M et al (1987) MR imaging of optic pathways in patients with neurofibromatosis. AJNR 8:1031–1036
Gill DS, Hyman SL, Stenberg A et al (2006) Age-related findings on MRI in neurofibromatosis type 1. Pediatr Radiol 31:1048–1056
DiPaolo DP, Zimmerman RA, Rorke LB et al (1995) Neurofibromatosis type 1: pathologic substrate of high signal intensity foci in the brain. Radiology 195:721–724
DeBella K, Poskitt K, Szudek J et al (2000) Use of “unidentified bright objects” on MRI for diagnosis of neurofibromatosis 1 in children. Neurology 54:1646–1651
Kim BS, Illes J, Kaplan RT et al (2002) Incidental findings on pediatric MR images of the brain. AJNR 23:1674–1677
Tognini G, Ferrozzi F, Garlaschi G et al (2005) Brain apparent diffusion coefficient evaluation in pediatric patients with neurofibromatosis type 1. J Comput Assist Tomogr 29:298–304
Hyman SL, Gill DS, Shores EA et al (2003) Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1. Neurology 60:1139–1145
Gurless RG (2000) Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children. Neurology 55:1067–1068
Lynch TM, Gutmann DH (2002) Neurofibromatosis 1. Neurol Clin 20:841–865
Palmer C, Szudek J, Joe H et al (2004) Analysis of neurofibromatosis 1 (NF1) lesions by body segment. Am J Med Genet A 125:157–161
Ruggieri M, Huson SM (2001) The clinical and diagnostic implications of mosaicism in the neurofibromatosis. Neurology 56:1433–1443
Thiagalingam S, Flaherty M, Billson F et al (2004) Neurofibromatosis type 1 and optic pathway gliomas. Ophthalmology 111:568–577
Kornreich L, Blaser S, Schwarz M et al (2001) Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis. AJNR 22:1963–1969
Jacquemin C, Bosley TM, Svedberg H (2003) Orbit deformities in craniofacial neurofibromatosis type 1. AJNR 24:1678–1682
Nichols JC, Amato JE, Chung SM (2003) Characteristics of Lisch nodules in patients with neurofibromatosis type 1. J Pediatr Ophthalmol Strabismus 40:293–296
Young H, Hyman S, North K (2002) Neurofibromatosis type 1: clinical review and exceptions to the rules. J Child Neurol 17:613–621
DiMario FJ, Ramsby G (1998) Magnetic resonance imaging lesion analysis in neurofibromatosis type 1. Arch Neurol 55:500–505
Griffiths PD, Blaser S, Mukonoweshuro W et al (1999) Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential? Pediatrics 104:e49
Katzman GL, Dagher AP, Patronas NJ (1999) Incidental findings on brain magnetic resonance imaging from 1,000 asymptomatic volunteers. JAMA 282:36–39
Kraut MA, Gerring JP, Cooper KL et al (2004) Longitudinal evolution of unidentified bright objects in children with neurofibromatosis-1. Am J Med Genet A 129:113–119
Ballesteros MC, Hansen PE, Soila K (1993) MR imaging of the developing human brain. Part 2. Postnatal development. Radiographics 13:611–622
Barkovich AJ, Kjos BO, Jackson DE Jr et al (1988) Normal maturation of the neonatal and infant brain: MR imaging at 1.5 T. Radiology 166(1Pt1):173–180
Itoh T, Magnaldi S, White RM et al (1994) Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities. AJNR 15:1513–1519
Mirowitz SA, Sartor K, Gado M (1989) High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis. AJNR 10:1159–1163
Terada H, Barkovich AJ, Edwards MS et al (1996) Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1. AJNR 17:755–760
Raininko R, Thelin L, Eeg-Olofsson O (2001) Atypical focal non-neoplastic brain changes in neurofibromatosis type 1: mass effect and contrast enhancement. Neuroradiology 43:586–590
Van Es S, North KN, McHugh K et al (1996) MRI findings in children with neurofibromatosis type 1: a prospective study. Pediatr Radiol 26:478–487
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lopes Ferraz Filho, J.R., Munis, M.P., Soares Souza, A. et al. Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1. Pediatr Radiol 38, 305–310 (2008). https://doi.org/10.1007/s00247-007-0712-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-007-0712-x